Navigation Links
Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
Date:12/9/2009

with the endoscopy procedures. The most commonly reported SAE following endoscopy was acute pancreatitis requiring hospitalization.

"Although this study did not achieve the pre-specified statistical outcome for the primary endpoint, it provides further evidence of the benefits of RG1068 in MRI imaging of the pancreas," stated Walter C. Herlihy, President and Chief Executive Officer of Repligen Corporation. "Further development plans for RG1068 will be determined following discussion of these results with the FDA next quarter."

This was a multi-center, baseline controlled, single dose study in which 258 patients with a history of pancreatitis at 23 clinical sites within the U.S. and Canada received an MRI of the pancreas with and without RG1068, and independently an endoscopic procedure called ERCP. The MRI imaging results were randomized and independently evaluated by three radiologists blinded to the details of the MRI procedures for evaluation of pancreatic duct abnormalities, image quality, number of duct segments visualized and confidence in diagnosis. The use of MRI is attractive for patient care as it can obviate the need for more risky invasive procedures such as ERCP.

RG1068 is a synthetic version of human secretin, a natural gastrointestinal hormone involved in the process of digestion. Secretin has been used for many years by gastroenterologists in conjunction with ERCP, an invasive procedure to evaluate and treat diseases of the pancreas and gallbladder. There are risks associated with the use of ERCP, which have generated interest in the development of safer non-invasive tests to diagnose gastrointestinal disorders. The use of RG1068 in combination with a non-invasive procedure such as MRI can improve the detection of abnormalities and increase the diagnostic quality of the MRI image of the pancreas. The FDA has granted RG1068 Orphan Drug status and Fast Track Designation, a process designed to facilitate the deve
'/>"/>

SOURCE Repligen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder
2. Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging
3. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
4. Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder
5. ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Maintaining Remission in Patients with Crohns Disease
6. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
7. TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting
8. Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution
9. Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis
10. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
11. ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... GABLES, Fla. , Nov. 20, 2014   ... to become the first U.S. commercial producer of Molybdenum-99 ... a contract with INVAP to design its ... Fla. Mo-99 is the parent isotope of ... medicine procedures worldwide. In 2012, Congress passed legislation making ...
(Date:11/18/2014)... LAWRENCE, Mass. , Nov. 18, 2014 /PRNewswire/ ... NXTM ), a leading manufacturer of innovative ... its new  Streamline® Express dialyzer for the ... blood tubing set, which is designed to reduce ... and to reduce the number of touch point ...
(Date:11/18/2014)... Investor-Edge has initiated coverage on the following equities: ... GERN ), Tekmira Pharmaceuticals Corporation (NASDAQ: ... and XOMA Corporation (NASDAQ: XOMA ). Free research ... . The US markets on Monday, November 17, ... Industrial Average finished at 17,647.75, up 0.07% and the NASDAQ ...
Breaking Medicine Technology:Coqui RadioPharmaceuticals Inks Deal With INVAP 2NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set 2Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 2Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 3Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 4Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 5
... 2011 MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) ... featured in one oral presentation and four poster presentations at ... (AAN) in Honolulu, Hawaii April 9-16, 2011. A ... abstracts can be accessed at the AAN website at ...
... Inc. (Nasdaq: MYL ) today announced that its ... U.S. Food and Drug Administration (FDA) for its Abbreviated New ... mg and 400 mg, the generic version of Pfizer,s Neurontin ... shingles. Gabapentin Capsules had U.S. sales of ...
Cached Medicine Technology:MAP Pharmaceuticals to Present Data on LEVADEX™ at the 63rd Annual Meeting of the American Academy of Neurology 2MAP Pharmaceuticals to Present Data on LEVADEX™ at the 63rd Annual Meeting of the American Academy of Neurology 3MAP Pharmaceuticals to Present Data on LEVADEX™ at the 63rd Annual Meeting of the American Academy of Neurology 4
(Date:11/21/2014)... Even with years of experience under his belt, Kirk ... growth, participating in two recent events for his State Farm ... networking event with the leaders of State Farm and thousands ... and greatest in insurance news and products for his clients. ... (Stacy, Anthony, Reina and Jacob) as exhibitors at the recent ...
(Date:11/21/2014)... TX (PRWEB) November 21, 2014 ... facility at 7am today. The new facility is located ... open 24-7. , “We are pleased to join ... highest quality emergency medical care here,” said Dr. Siddiqi, ... , To celebrate the opening, First Choice ...
(Date:11/21/2014)... HealthDay Reporter THURSDAY, Nov. 20, 2014 ... of a still-beating heart has the potential to improve the ... new study. Heart patients who received the gel implant ... hundreds of feet farther during a six-minute walk test, said ... cardiovascular division at Washington University School of Medicine and a ...
(Date:11/21/2014)... 20, 2014 (HealthDay News) -- Kidney donation is one ... another. And now a new study finds that former donors ... benefiting from policies that give them priority on the transplant ... of the 16,900 kidney transplants that took place in the ... the study researchers. At the time of donation, ...
(Date:11/18/2014)... Hawthorne cosmetic dentist , Dr. Yashari, is now ... of Americans over the age of 35 are missing a ... are missing not just one but all of their natural ... offers a look, feel, and function that closely resembles that ... consultation that allows patients to learn more about their options. ...
Breaking Medicine News(10 mins):Health News:Kirk Martin Insurance Agency Goes Local and National with State Farm 2Health News:First Choice Emergency Room Opens New Facility in Friendswood, Texas 2Health News:Gel Implant Might Help Fight Heart Failure 2Health News:Gel Implant Might Help Fight Heart Failure 3Health News:Study Supports Giving Kidney Donors Priority When They Need a Kidney 2Health News:Hawthorne Dentist, Dr. Yashari, is Now Making Dental Implants More Affordable for Patients 2
... With seedlings and shoots still poking their leafy tops ... published research of Brown University biologist Alison DeLong without musing ... spring in spring. DeLong,s paper, published in advance online ... insights into the intricate network of proteins that controls plant ...
... 18, 2011 Illicit drug overdose deaths declined dramatically ... facility located in Vancouver, Canada, according to the findings ... Lancet. In the first peer-reviewed ... on overdose mortality, researchers observed a 35% reduction in ...
... EDITORS: Photo available at http://today.uci.edu/news/2011/04/nr_ptips_110421.php Irvine, Calif., ... will use a $3.2 million National Institutes of ... at lessening the anxiety and pain children feel ... professor and chair of anesthesiology & perioperative care, ...
... and working memory may result from an improved ability ... rhythm. This rhythm is thought to "turn down the ... value of meditation may be helping the brain deal ... (MGH), Harvard Medical School and the Massachusetts Institute of ...
... high school athlete drops dead, the rare but fatal ... reasons that remain a mystery to scientists, some young ... an unusual heart arrhythmia. With over-exertion, their hearts stop ... screening for the hard-to-detect syndrome has been prohibitively expensive. ...
... Pediatric Dermatology reveals that routine, long-term use of topical ... any significant, negative side effects. Parental phobia of TCS is ... commonest fear is that TCS use will "thin the skin." ... including pharmacists. Led by Gayle Fischer, MBBS, FACD, of The ...
Cached Medicine News:Health News:In time for spring, biologist illuminates how seedlings regulate growth 2Health News:Deaths from drug overdose decline 35 percent after the opening of supervised injection site 2Health News:UCI anesthesiologist to lead study on alleviating surgical anxiety, pain in children 2Health News:Meditation may help the brain 'turn down the volume' on distractions 2Health News:Meditation may help the brain 'turn down the volume' on distractions 3Health News:Standing up for athletes at risk 2
IDS Rapid One, a microbial identification system....
IDS Rapid NF Plus, a microbial identification system....
Versatrek 240 is versatile as four tests can be performed on one platform such as blood culture, sterile body fluids, mycobacteria and mycobacteria susceptibility testing. This model comes equipped w...
BD Phoenix is an automated microbiology system used for identification and susceptibility testing....
Medicine Products: